Growth Metrics

Oncology Institute (TOI) Cash from Investing Activities (2020 - 2025)

Oncology Institute's Cash from Investing Activities history spans 6 years, with the latest figure at -$1.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 39.6% year-over-year to -$1.1 million; the TTM value through Dec 2025 reached -$3.1 million, down 106.65%, while the annual FY2025 figure was -$3.1 million, 106.65% down from the prior year.
  • Cash from Investing Activities reached -$1.1 million in Q4 2025 per TOI's latest filing, down from -$604000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $24.9 million in Q2 2023 to a low of -$87.8 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$1.9 million, with a median of -$778500.0 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: tumbled 9139.89% in 2022, then surged 1936.43% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$9.2 million in 2021, then plummeted by 255.93% to -$32.6 million in 2022, then soared by 135.7% to $11.6 million in 2023, then tumbled by 115.09% to -$1.8 million in 2024, then skyrocketed by 39.6% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Cash from Investing Activities are -$1.1 million (Q4 2025), -$604000.0 (Q3 2025), and -$1.2 million (Q2 2025).